Interested in Patient Education and Pelvic Pain? Are you currently a trainee? Want to attend the Annual Meeting October 12-15, 2017 in Washington DC with complimentary registration?... If so, become a Patient Advocate Reporter!
As part of the IPPS mission we would like to inform patients with pelvic pain about the newest developments in the diagnosis and treatment of pelvic pain. We will select 2 IPPS members to act as Patient Advocate Reporters at the IPPS Annual Meeting. Reporters will attend the meeting and each will select at least 3 sessions that they found most interesting and applicable to the patient with pelvic pain. They will write a 1 page summary in lay language for each session. (The 2 reporters must select 3 different lectures, for a total of 6 patient-centered articles). These articles will be posted on our website and available for the public to view. In return, each Patient Advocate Reporter will receive complementary registration for the Scientific Meeting.
How to apply to become a Patient Advocate Reporter:
Interested applicants must be trainees (e.g. resident, medical student, or physical therapy trainee) with an interest in chronic pelvic pain. Applicants should submit a statement of interest, their CV, and documentation of training status to Donna at WJ Weiser via email@example.com. The statement of interest should outline why you would like to be a Patient Advocate Reporter, your prior writing experience, and any other pertinent experiences you have. Limit your statement to 500 words or less.
Patient Advocate Reporters will be given complementary registration to the Scientific IPPS Fall Annual Meeting. Reporters will need to provide their own transportation and accommodation. Registration fees for the Pre-conference Basics Session, Post-Conference or optional events are not included in the complementary registration.
Reporters must be a member of the IPPS in order to apply.
Applications are due by August 1, 2017. Two (2) Reporters will be selected by the IPPS Executive Board and will be announced by September 1, 2017.